Company profile
Desktop Genetics Ltd is a UK company with status active founded in 2012 based in West Midlands.
Updated 06 Jun 2026 16:52
Financial period: 1 Jan 2024 to 31 Dec 2024
Reference milestones and recent Companies House filing stream events.
Next accounts due date
Next confirmation statement due date
Last confirmation statement made up date
Last accounts made up date
CS01 | Transaction MzQzNTA2NTkzMGFkaXF6a2N4
Published 10 Sep 2024 09:18
Company registered at Companies House
1 Feb 2016 to 31 Jan 2018
Epigenome editing provides an opportunity to reverse aberrant epigenetic drivers of diseases such as cancer where epigenetic change drives tumour evolution and determines treatment success. Adapting CRISPR/Cas9 genome editing to the clinic requires the integration of large, heterogeneous biological data sets into a unified in silico cellular model suitabl...
1 Nov 2013 to 30 Apr 2015
Artificial genes made from synthetic DNA are vital to new drug research in oncology, infectious diseases and regenerative medicine, as well as the production of high-value chemicals, biofuels, and many other industrial products. Current manual gene assembly methods are laborious, time-consuming, and typically yield only 25 error-free genes per 100 attempt...
1 Feb 2013 to 31 Jul 2013
Desktop Genetics is developing a rapid prototyping solution for biotechnology. Researchers in the industry require synthetic genes to engineer new biopharmaceutical drugs, high value chemicals and biofuels, but lack the tools to effectively make these genes. Constrained to buying them from service providers, they waste resources waiting for these to arriv...
